Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BAX
HALO
Add up to 3 more stocks
BAX
Baxter International Inc.
+0.56%
$24.36+0.14Delayed quote: Oct 6, 2026, 3:59 PM EDT
Market Cap
$12.59B
52W Range
$15.73 - $30.00
HALO
Halozyme Therapeutics, Inc.
+1.30%
$109.72+1.41Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$13.01B
52W Range
$61.23 - $116.85
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 32.75 |
| Forward P/E | 11.86 | 13.04 |
| PEG Ratio | N/A | 1.43 |
| P/B Ratio | 2.03 | 90.66 |
| P/S Ratio | 1.10 | 7.82 |
| P/FCF Ratio | 18.57 | 16.14 |
| EV/EBITDA | 29.61 | 14.22 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 30.1% | 78.2% |
| Operating Margin | -2.4% | 56.8% |
| Net Margin | -9.3% | 24.9% |
| ROE | -17.1% | 288.1% |
| ROA | -5.4% | 16.1% |
| ROIC | -1.6% | 27.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.95 | 2.71 |
| Quick Ratio | 1.32 | 2.31 |
| Debt/Equity | 1.56 | 14.95 |
| Interest Coverage | -1.06 | 45.03 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.2% | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.